Innovative Vaccine Approaches
June 28-30, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change
Preferred
(EDT)
Filters
Any Time
Content
Dates
Tracks
Speakers
Showing results 1 - 7 of 7
Monday, June 28, 2021
Welcoming Remarks and Keynote Address
9:00 AM - 9:40 AM EDT
Monday, June 28, 2021Co-Chairs
Mariagrazia Pizza, PhD
GlaxoSmithKline Vaccines
Galit Alter, PhD
MIT and Harvard University
Welcoming Remarks and Keynote Address
Vaccines 2030
9:00 AM - 9:40 AM EDT
Monday, June 28, 2021Speaker
Rino Rappuoli, PhD
GlaxoSmithKline Vaccines
Welcoming Remarks and Keynote Address
Shifting the Paradigm in Global Health and AMR
9:40 AM - 12:40 PM EDT
Monday, June 28, 2021Co-Chairs
Galit Alter, PhD
MIT and Harvard University
Keith Klugman
Bill and Melinda Gates Foundation
Shifting the Paradigm in Global Health and AMR
The Role of Vaccines in Combatting Antimicrobial Resistance (AMR)
9:40 AM - 10:05 AM EDT
Monday, June 28, 2021Speaker
Elizabeth Klemm, PhD
Wellcome Trust
Shifting the Paradigm in Global Health and AMR
Oral Vaccine Induced Immunity in Lower Income Settings
10:05 AM - 10:30 AM EDT
Monday, June 28, 2021Speaker
Gagandeep Kang, MD, PhD
Christian Medical College/Translational Health Science and Technology Institute
Shifting the Paradigm in Global Health and AMR
Challenges in the Field
10:30 AM - 10:55 AM EDT
Monday, June 28, 2021Speaker
Ankur Mutreja, PhD
University of Cambridge
Shifting the Paradigm in Global Health and AMR
Coffee Break
10:55 AM - 11:20 AM EDT
Monday, June 28, 2021Shifting the Paradigm in Global Health and AMR
An Invariant Trypanosoma Vivax Vaccine Antigen Induces Protective Immunity
11:20 AM - 11:45 AM EDT
Monday, June 28, 2021Speaker
Gavin Wright, PhD
Wellcome Trust Sanger Institute
Shifting the Paradigm in Global Health and AMR
GMMA as Antigen and Delivery System
11:45 AM - 12:10 PM EDT
Monday, June 28, 2021Speaker
Mariagrazia Pizza, PhD
GlaxoSmithKline Vaccines
Shifting the Paradigm in Global Health and AMR
Short Talk: Vaccine Driven Lung TRM Cells Provide Immunity Against Klebsiella via Fibroblast IL-17R Signaling
12:25 PM - 12:40 PM EDT
Monday, June 28, 2021Speaker
Joseph Hoffmann, PhD
Tulane University School of Medicine
Shifting the Paradigm in Global Health and AMR
Meet the Editors Roundtable
2:30 PM - 3:30 PM EDT
Monday, June 28, 2021Speakers
Alexandra Flemming
Nature Publishing Group
Paula Onieva
PLOS (Public Library of Science)
Ines Pires
Frontiers In Tropical Diseases
Gaia Trincucci, PhD
Journal of Experimental Medicine
Keystone Symposia Roundtables
Tuesday, June 29, 2021
COVID and Pan COVID Vaccines: Technologies and Criticalities
9:00 AM - 12:25 PM EDT
Tuesday, June 29, 2021Co-Chairs
Lynda Stuart, MD, PhD
Bill & Melinda Gates Foundation
Gordon Dougan, PhD
University of Cambridge
COVID and Pan COVID Vaccines: Technologies and Criticalities
New Humoral OMIC Tools to Mine for Correlates of Immunity
9:00 AM - 9:25 AM EDT
Tuesday, June 29, 2021Speaker
Galit Alter, PhD
MIT and Harvard University
COVID and Pan COVID Vaccines: Technologies and Criticalities
mRNA Based Vaccines
9:25 AM - 9:50 AM EDT
Tuesday, June 29, 2021Speaker
Andrea Carfi, PhD
Moderna
COVID and Pan COVID Vaccines: Technologies and Criticalities
Viral Vectors
9:50 AM - 10:15 AM EDT
Tuesday, June 29, 2021Speaker
Andrew Pollard, MD, PhD
University of Oxford
COVID and Pan COVID Vaccines: Technologies and Criticalities
From Diversity to Protection
10:15 AM - 10:40 AM EDT
Tuesday, June 29, 2021Speaker
Florian Krammer, PhD
Icahn School of Medicine at Mount Sinai
COVID and Pan COVID Vaccines: Technologies and Criticalities
SARS-COV2 Spread and Evolution to Instruct Pan- Vaccine Development Strategies
10:40 AM - 11:05 AM EDT
Tuesday, June 29, 2021Speaker
Ravi Gupta, MD
University of Cambridge
COVID and Pan COVID Vaccines: Technologies and Criticalities
Coffee Break
11:05 AM - 11:30 AM EDT
Tuesday, June 29, 2021COVID and Pan COVID Vaccines: Technologies and Criticalities
Epidemiological and Evolutionary Considerations of SARS-CoV-2 Vaccine Administration Schemes
11:30 AM - 11:55 AM EDT
Tuesday, June 29, 2021Speaker
Caroline Wagner, PhD
McGill University
COVID and Pan COVID Vaccines: Technologies and Criticalities
Short Talk: INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T Cell Activity Against Global SARS-CoV-2 Variants
11:55 AM - 12:10 PM EDT
Tuesday, June 29, 2021Speaker
Viviane Machado, PhD
Inovio Pharmaceuticals Inc.
COVID and Pan COVID Vaccines: Technologies and Criticalities
Short Talk: Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates
12:10 PM - 12:25 PM EDT
Tuesday, June 29, 2021Speaker
Kayvon Modjarrad, MD, PhD
Walter Reed Army Institute of Research
COVID and Pan COVID Vaccines: Technologies and Criticalities
Pandemic Preparedness: Lessons from COVID
12:25 PM - 1:40 PM EDT
Tuesday, June 29, 2021Co-Chairs
Shabir Madhi, MD, PhD
South African Medical Research Council
Christopher Karp, MD
Bill & Melinda Gates Foundation
Pandemic Preparedness: Lessons from COVID
Planning for Correlates for Phase 3 Studies: Lessons from COVID
12:25 PM - 12:40 PM EDT
Tuesday, June 29, 2021Speakers
Lawrence Corey, MD
Fred Hutchinson Cancer Research Center
Peter Gilbert, PhD
Fred Hutchinson Cancer Research Center
Pandemic Preparedness: Lessons from COVID
Changing Regulatory and Vaccine Landscape in the Face of COVID
12:40 PM - 12:55 PM EDT
Tuesday, June 29, 2021Speaker
Gordon Dougan, PhD
University of Cambridge
Pandemic Preparedness: Lessons from COVID
Strategies to Manufacturing, Distribution and Roll-out
12:55 PM - 1:10 PM EDT
Tuesday, June 29, 2021Speaker
Nicole Lurie, MD
Coalition for Epidemic Preparedness Innovations - CEPI
Pandemic Preparedness: Lessons from COVID
Panel Discussion
1:10 PM - 1:40 PM EDT
Tuesday, June 29, 2021Pandemic Preparedness: Lessons from COVID
Career Roundtables
3:30 PM - 4:30 PM EDT
Tuesday, June 29, 2021Speakers
Sanjay Ram, MD
University of Massachusetts
Amy Gilbert, PhD
Adaptive Biotechnologies
Elizabeth Klemm, PhD
Wellcome Trust
Keystone Symposia Roundtables
Wednesday, June 30, 2021
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
9:00 AM - 1:00 PM EDT
Wednesday, June 30, 2021Co-Chairs
Gordon Dougan, PhD
University of Cambridge
Mariagrazia Pizza, PhD
GlaxoSmithKline Vaccines
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
Towards a Pan-Sarbecovirus Vaccine
9:00 AM - 9:25 AM EDT
Wednesday, June 30, 2021Speaker
Pamela Bjorkman, PhD
California Institute of Technology
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
SARS-Cov2 Human Challenge
9:25 AM - 9:50 AM EDT
Wednesday, June 30, 2021Speaker
Christopher Chiu, MD, PhD
Imperial College London
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
Immune Correlates of Protection from Tuberculosis
9:50 AM - 10:15 AM EDT
Wednesday, June 30, 2021Speaker
Elisa Nemes, PhD
University of Cape Town
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
Pneumococcal Human Infection Study in Malawi to Understand Vaccine Efficacy
10:15 AM - 10:40 AM EDT
Wednesday, June 30, 2021Speaker
Stephen Gordon, MD, PhD
Liverpool School of Tropical Medicine
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
Human Infection Model of Group A Streptococcus Pharyngitis
10:40 AM - 11:05 AM EDT
Wednesday, June 30, 2021Speaker
Andrew Steer, MD
Murdoch Children's Research Institute
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
Coffee Break
11:05 AM - 11:30 AM EDT
Wednesday, June 30, 2021Immune Correlates: 'In vivo' and 'in vitro' Model Systems
Innovative 3D Infection Models as Validation Tools for Vaccine Research
11:30 AM - 11:55 AM EDT
Wednesday, June 30, 2021Speaker
Thomas Rudel, PhD
University of Würzburg
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
Single Cell Omics from SARS-COV2 Spread and Evolution to Instruct Pan-Vaccine Development Strategies
11:55 AM - 12:20 PM EDT
Wednesday, June 30, 2021Speaker
Catherine Blish, MD, PhD
Stanford University School of Medicine
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
Short Talk: Activation and Kinetics of Circulating Tfh Cells, Specific Plasmablast Response and Development of Neutralizing Antibodies Following Yellow Fever Virus Vaccination
12:20 PM - 12:35 PM EDT
Wednesday, June 30, 2021Speaker
John Sandberg, MS
Karolinska Institutet
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
Short Talk: Cytosolic dsRNA Improves Neonatal Innate Immune Responses to Adjuvants Currently in Use in Paediatric Vaccines
12:35 PM - 12:50 PM EDT
Wednesday, June 30, 2021Speaker
Kiva Brennan, PhD
Trinity College Dublin
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
Closing Remarks
12:50 PM - 1:00 PM EDT
Wednesday, June 30, 2021Speaker
Gordon Dougan, PhD
University of Cambridge
Immune Correlates: 'In vivo' and 'in vitro' Model Systems
